Difference between revisions of "Part:BBa K1202008"

 
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K1202008 short</partinfo>
 
<partinfo>BBa_K1202008 short</partinfo>
  
Induces apoptosis in cancer cells.
+
E4orf4 is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of e4orf4 is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy.
 +
 
 +
This protein is planned as alternative for apoptin cancer killing peptide.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 23:31, 4 October 2013

E4orf4

E4orf4 is a novel prospective cancer drug which induces programmed cell death (apoptosis) phase of normal cell life cycle in cancer cells, selectively. The exact mechanism of e4orf4 is not understood, yet. But, the efficiency and results of the function are researched and pose promising hopeful results for efficient cancer therapy.

This protein is planned as alternative for apoptin cancer killing peptide.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 9
    Illegal NgoMIV site found at 18
  • 1000
    COMPATIBLE WITH RFC[1000]